Adjuvant 5-FU based chemotherapy for colon cancer: Match or miss the mismatch?

被引:2
作者
D'Incalci, Maurizio [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Dept Oncol, I-20156 Milan, Italy
关键词
REPAIR;
D O I
10.1016/j.ejca.2008.10.040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:316 / 317
页数:2
相关论文
共 5 条
[1]  
CATAPANO CV, 1987, CANCER RES, V47, P4884
[2]   Targeting DNA repair as a promising approach in cancer therapy [J].
Damia, Giovanna ;
D'Incalci, Maurizio .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (12) :1791-1801
[3]   MGMT gene silencing and benefit from temozolomide in glioblastoma [J].
Hegi, ME ;
Diserens, A ;
Gorlia, T ;
Hamou, M ;
de Tribolet, N ;
Weller, M ;
Kros, JM ;
Hainfellner, JA ;
Mason, W ;
Mariani, L ;
Bromberg, JEC ;
Hau, P ;
Mirimanoff, RO ;
Cairncross, JG ;
Janzer, RC ;
Stupp, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :997-1003
[4]   The multifaceted mismatch-repair system [J].
Jiricny, J .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (05) :335-346
[5]   The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status [J].
Jover, Rodrigo ;
Zapater, Pedro ;
Castells, Antoni ;
Llord, Xavier ;
Andreu, Montserrat ;
Cubiella, Joaquin ;
Balaguer, Francesc ;
Sempere, Laura ;
Xicola, Rosa M. ;
Bujanda, Luis ;
Rene, Josep M. ;
Clofent, Juan ;
Bessa, Xavier ;
Morillas, Juan D. ;
Nicolas-Perez, David ;
Pons, Elisenda ;
Paya, Artemio ;
Alenda, Cristina .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (03) :365-373